FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2055074145> ?p ?o ?g. }

• W2055074145 endingPage "10734" @default.
• W2055074145 startingPage "10725" @default.
• W2055074145 abstract "microRNAs (miRNAs) regulate gene expression at the post-transcriptional level and play important roles in tumor initiation and progression. Recently, we examined the global miRNA expression profile of esophageal squamous cell carcinoma (ESCC) and demonstrated that miR-92a was highly expressed in tumor tissues. In this study, we found that the up-regulation of miR-92a was significantly correlated with the status of lymph node metastasis and TNM stage in 107 ESCC patients. Moreover, the up-regulation of miR-92a was associated with poor survival of ESCC patients and might be used as an independent prognostic factor. Next, we investigated the role and mechanism of miR-92a in ESCC cells, and found that miR-92a modulated the migration and invasion but not apoptosis and proliferation of ESCC cells in vitro. We further demonstrated that miR-92a directly targeted the CDH1 3′-UTR and repressed the expression of CDH1, a tumor metastasis suppressor. In addition, restoring of miR-92a-resistant CDH1 expression in miR-92a-overexpression cells recovered the pro-metastasis activity of miR-92a. Taken together, we demonstrated that miR-92a promotes ESCC cell migration and invasion at least partially via suppression of CDH1 expression, and patients with up-regulated miR-92a are prone to lymph node metastasis and thus have poor prognosis. microRNAs (miRNAs) regulate gene expression at the post-transcriptional level and play important roles in tumor initiation and progression. Recently, we examined the global miRNA expression profile of esophageal squamous cell carcinoma (ESCC) and demonstrated that miR-92a was highly expressed in tumor tissues. In this study, we found that the up-regulation of miR-92a was significantly correlated with the status of lymph node metastasis and TNM stage in 107 ESCC patients. Moreover, the up-regulation of miR-92a was associated with poor survival of ESCC patients and might be used as an independent prognostic factor. Next, we investigated the role and mechanism of miR-92a in ESCC cells, and found that miR-92a modulated the migration and invasion but not apoptosis and proliferation of ESCC cells in vitro. We further demonstrated that miR-92a directly targeted the CDH1 3′-UTR and repressed the expression of CDH1, a tumor metastasis suppressor. In addition, restoring of miR-92a-resistant CDH1 expression in miR-92a-overexpression cells recovered the pro-metastasis activity of miR-92a. Taken together, we demonstrated that miR-92a promotes ESCC cell migration and invasion at least partially via suppression of CDH1 expression, and patients with up-regulated miR-92a are prone to lymph node metastasis and thus have poor prognosis." @default.
• W2055074145 created "2016-06-24" @default.
• W2055074145 creator A5002090022 @default.
• W2055074145 creator A5002386105 @default.
• W2055074145 creator A5010596222 @default.
• W2055074145 creator A5020273118 @default.
• W2055074145 creator A5022348147 @default.
• W2055074145 creator A5035239774 @default.
• W2055074145 creator A5038207493 @default.
• W2055074145 creator A5042877654 @default.
• W2055074145 creator A5055979464 @default.
• W2055074145 creator A5065058975 @default.
• W2055074145 creator A5070580880 @default.
• W2055074145 creator A5071213444 @default.
• W2055074145 creator A5076028592 @default.
• W2055074145 creator A5081351512 @default.
• W2055074145 creator A5081419130 @default.
• W2055074145 date "2011-03-01" @default.
• W2055074145 modified "2023-10-17" @default.
• W2055074145 title "microRNA-92a Promotes Lymph Node Metastasis of Human Esophageal Squamous Cell Carcinoma via E-Cadherin" @default.
• W2055074145 cites W1607015107 @default.
• W2055074145 cites W1966241991 @default.
• W2055074145 cites W1967532587 @default.
• W2055074145 cites W1968967714 @default.
• W2055074145 cites W1969003435 @default.
• W2055074145 cites W1972027926 @default.
• W2055074145 cites W1972039621 @default.
• W2055074145 cites W1978944350 @default.
• W2055074145 cites W1982574859 @default.
• W2055074145 cites W1982765892 @default.
• W2055074145 cites W1985805477 @default.
• W2055074145 cites W1989910375 @default.
• W2055074145 cites W1999504188 @default.
• W2055074145 cites W2000051229 @default.
• W2055074145 cites W2006329675 @default.
• W2055074145 cites W2006767098 @default.
• W2055074145 cites W2008955962 @default.
• W2055074145 cites W2020830322 @default.
• W2055074145 cites W2039213901 @default.
• W2055074145 cites W2044782990 @default.
• W2055074145 cites W2047529648 @default.
• W2055074145 cites W2050079849 @default.
• W2055074145 cites W2056302937 @default.
• W2055074145 cites W2062290101 @default.
• W2055074145 cites W2068269490 @default.
• W2055074145 cites W2070332016 @default.
• W2055074145 cites W2085592081 @default.
• W2055074145 cites W2093921289 @default.
• W2055074145 cites W2098139456 @default.
• W2055074145 cites W2102298903 @default.
• W2055074145 cites W2112798314 @default.
• W2055074145 cites W2119709720 @default.
• W2055074145 cites W2125120607 @default.
• W2055074145 cites W2128265523 @default.
• W2055074145 cites W2130808338 @default.
• W2055074145 cites W2145021085 @default.
• W2055074145 cites W2145187069 @default.
• W2055074145 cites W2150203365 @default.
• W2055074145 cites W2150536104 @default.
• W2055074145 cites W2152653683 @default.
• W2055074145 cites W2154644298 @default.
• W2055074145 doi "https://doi.org/10.1074/jbc.m110.165654" @default.
• W2055074145 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3060523" @default.
• W2055074145 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21148309" @default.
• W2055074145 hasPublicationYear "2011" @default.
• W2055074145 type Work @default.
• W2055074145 sameAs 2055074145 @default.
• W2055074145 citedByCount "128" @default.
• W2055074145 countsByYear W20550741452012 @default.
• W2055074145 countsByYear W20550741452013 @default.
• W2055074145 countsByYear W20550741452014 @default.
• W2055074145 countsByYear W20550741452015 @default.
• W2055074145 countsByYear W20550741452016 @default.
• W2055074145 countsByYear W20550741452017 @default.
• W2055074145 countsByYear W20550741452018 @default.
• W2055074145 countsByYear W20550741452019 @default.
• W2055074145 countsByYear W20550741452020 @default.
• W2055074145 countsByYear W20550741452021 @default.
• W2055074145 countsByYear W20550741452022 @default.
• W2055074145 countsByYear W20550741452023 @default.
• W2055074145 crossrefType "journal-article" @default.
• W2055074145 hasAuthorship W2055074145A5002090022 @default.
• W2055074145 hasAuthorship W2055074145A5002386105 @default.
• W2055074145 hasAuthorship W2055074145A5010596222 @default.
• W2055074145 hasAuthorship W2055074145A5020273118 @default.
• W2055074145 hasAuthorship W2055074145A5022348147 @default.
• W2055074145 hasAuthorship W2055074145A5035239774 @default.
• W2055074145 hasAuthorship W2055074145A5038207493 @default.
• W2055074145 hasAuthorship W2055074145A5042877654 @default.
• W2055074145 hasAuthorship W2055074145A5055979464 @default.
• W2055074145 hasAuthorship W2055074145A5065058975 @default.
• W2055074145 hasAuthorship W2055074145A5070580880 @default.
• W2055074145 hasAuthorship W2055074145A5071213444 @default.
• W2055074145 hasAuthorship W2055074145A5076028592 @default.
• W2055074145 hasAuthorship W2055074145A5081351512 @default.
• W2055074145 hasAuthorship W2055074145A5081419130 @default.
• W2055074145 hasBestOaLocation W20550741451 @default.
• W2055074145 hasConcept C104317684 @default.

• next